XRCC3 Thr241Met Polymorphism is not Associated with Lung Cancer Risk in a Romanian Population.

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• DNA repair mechanisms are crucial for genome integrity and cancer prevention.
• Genetic variations in DNA repair genes, like XRCC3, may influence cancer susceptibility.
• The XRCC3 Thr241Met polymorphism is one such variation investigated for its role in carcinogenesis.

Purpose of the Study:

• To investigate the association between the XRCC3 Thr241Met polymorphism and lung cancer risk.
• To determine if this specific genetic variation impacts DNA repair efficiency and subsequent cancer development.
• To analyze this association within a Romanian population cohort.

Main Methods:

• Genotyping of the XRCC3 Thr241Met polymorphism using multiplex Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP).
• Study included 93 healthy controls and 85 lung cancer patients, all of whom were smokers.
• Statistical analysis was performed using the odds ratio (OR) in a recessive model.

Main Results:

• No increased risk of lung cancer was found for the variant 241Met allele or Thr241Met genotypes (p=0.138, OR=0.634).
• A statistically significant result was observed for the recessive model (p=0.023, OR=0.257), suggesting a potential protective effect, though further investigation is warranted.
• No associations were found between the XRCC3 Thr241Met polymorphism and gender, smoking status, or histopathological tumor type.

Conclusions:

• The XRCC3 Thr241Met polymorphism is not associated with an increased risk of lung cancer in the Romanian population studied.
• The findings suggest this specific genetic variation may not be a significant risk factor for lung cancer development in this cohort.
• Further research may be needed to fully elucidate the role of XRCC3 polymorphisms in lung carcinogenesis.